OVN — Oventus Medical Income Statement
0.000.00%
Last trade - 00:00HealthcareAdventurousMicro Cap
Annual income statement for Oventus Medical, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2017 June 30th | 2018 June 30th | C2019 June 30th | 2020 June 30th | 2021 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.537 | 0.271 | 0.332 | 0.419 | 1.09 |
| Cost of Revenue | |||||
| Gross Profit | -0.046 | 0.094 | 0.174 | 0.188 | 0.402 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 7.1 | 6.42 | 8.49 | 10.7 | 11 |
| Operating Profit | -6.56 | -6.15 | -8.15 | -10.2 | -9.96 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -6.51 | -5.87 | -7.85 | -10.1 | -9.83 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -6.51 | -5.87 | -7.85 | -10.1 | -9.83 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -6.51 | -5.87 | -7.85 | -10.1 | -9.83 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -6.51 | -5.87 | -7.85 | -10.1 | -9.83 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.091 | -0.058 | -0.074 | -0.078 | -0.061 |
| Dividends per Share |